Ergon Capital Partners buys ELITech

The deal value has not been disclosed but the mid-cap investor financed the acquisition through its Ergon Capital Partners III fund.

Previous backers BNP Paribas Développement, Idia Participations, Naxicap and Synergie Finance all reinvested and continue to hold a stake in the company.

Elitech is headquartered in Salon de Provence and was formed in 2005 through the merger between the diagnostic divisions of biochemistry groups Biotech International and LDH.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Gregoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Healthcare
• Buyouts
• France